2006 Access Data Safety 
Cannabis Law Report
JULY 22, 2022
As the only track-and-trace company to have successfully taken over a government contract from another vendor, Metrc will replace the State’s current partner and implement its robust track-and-trace platform to help facilitate the Rhode Island Medical Cannabis Program’s data collection and regulatory oversight. and now Rhode Island.
Cannabis Law Report
JANUARY 23, 2022
Multivariate analysis of overall survival and nonrelapse mortality (NRM) data has shown GVHD likelihood can be impacted by age, prior acute GVHD, time from transplantation to cGVHD, donor type, disease status at transplantation, GVHD prophylaxis, gender mismatch, serum bilirubin, Karnofsky score, and platelet count (Arora et al. Implications.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
MAY 26, 2022
was published in the Journal of Safety Research and made available online on May 18. Journal of Safety Research. The objective of the current study was to assess the ease of access to marijuana by underage patrons at recreational marijuana outlets in California, where recreational marijuana was legalized in 2016.
Cannabis Law Report
NOVEMBER 24, 2021
However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive. Refractory paediatric epilepsy.
Cannabis Law Report
JANUARY 10, 2020
This continues to create challenges for marijuana businesses, including access to the payment and banking systems. xiii Dispensary counts are estimated using current business licensing data from Colorado Department of Revenue Enforcement Division. The data can be found here: [link]. Data from the Colorado State Patrol: [link].
Cannabis Law Report
APRIL 8, 2022
The FDA formally decided to open the door to psychedelic research in human participants, and later accepted MAPS’ Phase 1 MDMA safety and tolerance study protocol. MAPS completed the first Phase 1 safety study with MDMA and resumed working on a protocol for anxiety associated with cancer. Rick Doblin, Ph.D.,
Cannabis Law Report
OCTOBER 29, 2019
ElleVet Sciences is pleased to announce the results and publication of the first safety study on the use of hemp CBD/CBDA. The 12-week safety study, conducted by Dr. Joseph Wakshlag, DVM, Ph.D., This data gives us confidence in the use of both the chew and the oils as effective means for delivering CBD to your pet.”.
Expert insights. Personalized for you.
52 
Let's personalize your content